Such a treatment also may help determine how many people were exposed. With a limited supply of COVID-19 tests in the United States, people with mild symptoms are less likely to be tested, leaving ...

MARCY L’ÉTOILE, France--(BUSINESS WIRE)-- Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced performance validation and the upcoming launch ...

The Food and Drug Administration announced on Friday that it has authorized the first serology test that screens for neutralizing antibodies caused by a previous coronavirus infection. Neutralizing ...

LOS ANGELES, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the discovery, development and commercialization of ...

Expert Rev Anti Infect Ther. 2013;11(8):839-843. This group of serofast patients with unchanging serologic test titers are a source of anxiety and concern for clinicians, who are often uncertain as to ...